On self-quarantine. Anytime is good. Prior to
Post# of 36536
Prior to the CC, I would like to see a PR with 4 divisions. This would establish a framework for asking questions and might even answer some questions before we ask them.
Updates on S-1 filing, uplisting Generex to NASDAQ, update on NGIO spin-off, and update on China COVID-19 initiative
Grid showing recent sales or phases of testing for old and new drugs in the Generex stable.
Second grid showing integrations of companies purchased
Update of progress in developing the MSO
Each division should include comments from the big 6, as appropriate, including forward-looking statements.